Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Invitae Corporation    NVTA

INVITAE CORPORATION

(NVTA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/26/2020 10/27/2020 10/28/2020 10/29/2020 10/30/2020 Date
46.08(c) 48.13(c) 44.22(c) 43.76(c) 39.21(c) Last
1 669 473 2 478 105 1 891 530 2 984 054 3 988 069 Volume
+1.81% +4.45% -8.12% -1.04% -10.40% Change
More quotes
Financials (USD)
Sales 2020 259 M - -
Net income 2020 -444 M - -
Net Debt 2020 20,4 M - -
P/E ratio 2020 -11,3x
Yield 2020 -
Sales 2021 499 M - -
Net income 2021 -255 M - -
Net Debt 2021 95,0 M - -
P/E ratio 2021 -24,2x
Yield 2021 -
Capitalization 5 767 M 5 767 M -
EV / Sales 2020 22,3x
EV / Sales 2021 11,7x
Nbr of Employees 1 500
Free-Float 98,7%
More Financials
Company
Invitae Corporation utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. As of December 31, 2016, the Company's products consisted of assays totaling over 1,100 genes that could be used for... 
More about the company
Notations Surperformance© of Invitae Corporation
Trading Rating : Investor Rating :
More Ratings
All news about INVITAE CORPORATION
10/28INVITAE : Research Highlights Frequency of Genetic Risk Factors Among Men with P..
AQ
10/23INVITAE : to Announce Third Quarter 2020 Financial Results on Thursday, November..
PR
10/22INVITAE : and Pacific Biosciences Collaborate to Develop Whole Genome Sequencing..
AQ
10/08INVITAE : New Study Finds Germline Genetic Testing Detects Actionable Findings M..
PR
10/05INVITAE : Submission of Matters to a Vote of Security Holders (form 8-K/A)
AQ
10/05INVITAE CORP : Entry into a Material Definitive Agreement, Completion of Acquisi..
AQ
10/05INVITAE : Completes Transaction with ArcherDX to Bring Comprehensive Cancer Gene..
PR
10/04And the No. 1 Stock-Fund Managers Are... -- Journal Report
DJ
10/01INVITAE CORP : Submission of Matters to a Vote of Security Holders, Other Events..
AQ
09/11INVITAE CORP : Change in Directors or Principal Officers (form 8-K)
AQ
09/11INVITAE : Appoints Kimber Lockhart to its Board of Directors
PR
09/10PTC THERAPEUTICS : Launches PTC PINPOINT A Genetic Testing Program for Individua..
AQ
09/09INVITAE : PTC Therapeutics Launches PTC PINPOINT - A Genetic Testing Program for..
PR
09/01INVITAE : to Participate in the Morgan Stanley Virtual Global Healthcare Confere..
PR
08/04INVITAE : Reports Inducement Grants Under NYSE Rule 303A.08
PR
More news
News in other languages on INVITAE CORPORATION
08/14Deutsche Bank sieht Qiagen-Kurs nach gefloppter Übernahme durchstarten
06/24DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 24.06.2020 - 15.15 Uhr
06/24Qiagen winkt hoher Sondergewinn aus Verkauf einer US-Beteiligung
06/24Aktien Frankfurt Ausblick: Moderate Verluste erwartet
06/23KORREKTUR : Qiagen winkt hoher Sondergewinn durch Verkauf von US-Beteiligung
More news
Chart INVITAE CORPORATION
Duration : Period :
Invitae Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INVITAE CORPORATION
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 41,54 $
Last Close Price 39,21 $
Spread / Highest target 22,4%
Spread / Average Target 5,95%
Spread / Lowest Target -13,3%
EPS Revisions
Managers
NameTitle
Sean Emerson George Chairman, President & Chief Executive Officer
Kenneth D. Knight Chief Operating Officer
Shelly D. Guyer Chief Financial Officer
Robert Nussbaum Chief Medical Officer
Eric I. Aguiar Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
INVITAE CORPORATION143.09%5 767
EXACT SCIENCES CORPORATION33.90%18 627
GUARDANT HEALTH, INC.36.50%10 625
BGI GENOMICS CO., LTD.116.89%8 822
ADAPTIVE BIOTECHNOLOGIES CORPORATION54.01%6 257
SEEGENE INC--.--%6 007